Abstract:Background and Objectives: Oligodendrocytes (OL) and their myelin-forming processes are targeted and lost during the disease course of Multiple Sclerosis (MS), targeted by infiltrating leukocytes and their effector cytokines. Myelin repair is considered to be dependent on recruitment and differentiation of oligodendrocyte precursor cells (OPCs). The basis of failure of re-myelination during the disease course of MS remains to be defined. The aim of this study is to determine the impact of pro-inflammatory molecules tumor necrosis factor ⍺ (TNF⍺) and interferon gamma (IFN𝛾) on the differentiation of human OPCs. Methods: We generated human OPCs from induced pluripotent stem cells with a reporter gene under the OL-specific transcription factor SOX10. We treated the cells in vitro with TNF⍺ or IFN𝛾 and evaluated effects in terms of cell viability, expression of OL-lineage markers, and co-expression of astrocyte markers. To relate our findings to the molecular properties of OPCs as found in the MS brain we re-analyzed publicly available single nuclear RNAseq datasets. Results: Our analysis indicated that both TNF⍺ and IFN𝛾 decreased the proportion of cells differentiating into the OL-lineage; consistent with previous reports. We now observe the TNF⍺ effect is linked to aberrant OPC differentiation. A subset of O4+, reporter-positive cells co-expressed the astrocytic marker Aquaporin-4 (AQP4). On the transcriptomic level, the cells acquire an astrocyte-like signature alongside a conserved reactive phenotype. Analysis of single-nuclear RNAseq datasets from human MS brain revealed a subset of OPCs expressing an astrocytic signature. Discussion: In the context of MS, these results imply that OPCs are present but inhibited from differentiating along the OL-lineage, with a subset acquiring a reactive and stem-cell like phenotype, reducing their capacity to contribute towards repair. These findings help define a potential basis for the impaired myelin repair in MS and provide a prospective route for regenerative treatment.

Conversion of Astrocyte Cell Lines to Oligodendrocyte Progenitor Cells Using Small Molecules and Transplantation to Animal Model of Multiple Sclerosis

Conversion of Mouse Fibroblasts into Oligodendrocyte Progenitor-Like Cells Through a Chemical Approach.

Reprogrammed Astrocytes As a Potential Therapy for Neurodegenerative Disorders.

Efficient and Rapid Conversion of Human Astrocytes and ALS Mouse Model Spinal Cord Astrocytes into Motor Neuron-Like Cells by Defined Small Molecules

Oligodendrocyte progenitor cell transplant for MS

Nanoparticle-mediated conversion of primary human astrocytes into neurons and oligodendrocytes

Efficient generation of myelinating oligodendrocytes from primary progressive multiple sclerosis patients by induced pluripotent stem cells.

Direct conversion of mouse astrocytes into neural progenitor cells and specific lineages of neurons

Sox2-mediated transdifferentiation of hAT-MSCs into induced neural progenitor-like cells for remyelination therapies

Optimizing Culture Medium Composition to Improve Oligodendrocyte Progenitor Cell Yields In Vitro from Subventricular Zone-Derived Neural Progenitor Cell Neurospheres

Remyelination after Lysophosphatidyl Choline-Induced Demyelination Is Stimulated by Bone Marrow Stromal Cell-Derived Oligoprogenitor Cell Transplantation

Rapid and Efficient Differentiation of Rodent Neural Stem Cells into Oligodendrocyte Progenitor Cells

Direct Reprogramming of Mouse Fibroblasts to Neural Progenitors

Direct Conversion of Dermal Fibroblasts into Neural Progenitor Cells by a Novel Cocktail of Defined Factors.

A Novel Approach for Amplification and Purification of Mouse Oligodendrocyte Progenitor Cells

Oligodendrocyte progenitor programming and reprogramming: Toward myelin regeneration

Accelerated Generation of Oligodendrocyte Progenitor Cells from Human Induced Pluripotent Stem Cells by Forced Expression of Sox10 and Olig2

Pro-Inflammatory Molecules Implicated in Multiple Sclerosis Divert the Development of Human Oligodendrocyte Lineage Cells

Injectable shear-thinning hydrogels promote oligodendrocyte progenitor cell survival and remyelination in the central nervous system

In vivo chemical reprogramming of astrocytes into neurons

Discovery of Novel Cell Surface Markers for Purification of Embryonic Dopamine Progenitors for Transplantation in Parkinson's Disease Animal Models.